Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-001022

Options or other derivatives

  • Director acquired 6,820 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cohen Neil Harris Director 2022-03-07 Grant or award · Option to Purchase American Depositary Shares +6,820 6,820 D
Loading xslF345X03/zk2227455.xml…